Stronger supply chains for improved access to medicines

The European Commission’s proposal for a Critical Medicines Act seeks to tackle shortages by addressing supply chain vulnerabilities, such as poor diversification. The initiative also aims at strengthening the availability and accessibility of medicines for which patients encounter specific barriers (e.g., treatments for rare diseases). BEUC considers that the proposal goes in the right direction but should be further aligned with consumers’ needs and expectations.

This paper outlines our recommendations in relation to the:

1. Objectives of the Regulation
2. Designation of ‘Strategic projects’
3. Financial support by Member States
4. Financial support from the Union
5. Award criteria in public procurement
6. Safety stocks
7. Collaborative procurement
8. Critical Medicines Coordination Group
9. Transparency
10. Penalties
11. Evaluation